Pemetrexed versus pemetrexed plus carboplatin in pretreated patients with advanced non-small cell lung cancer (NSCLC): Pooled analysis of two randomized trials.
A. Ardizzoni
No relevant relationships to disclose
L. Boni
No relevant relationships to disclose
M. Tiseo
No relevant relationships to disclose
A. Vincent
No relevant relationships to disclose
R. Passalacqua
No relevant relationships to disclose
A. Camerini
No relevant relationships to disclose
R. Labianca
No relevant relationships to disclose
G. Genestreti
No relevant relationships to disclose
F. Zanelli
No relevant relationships to disclose
L. Ciuffreda
No relevant relationships to disclose
F. Di Costanzo
No relevant relationships to disclose
F. De Marinis
No relevant relationships to disclose
L. Crinò
No relevant relationships to disclose
A. Santo
No relevant relationships to disclose
A. Pazzola
No relevant relationships to disclose
F. Barbieri
No relevant relationships to disclose
N. Zilembo
No relevant relationships to disclose
I. Colantonio
No relevant relationships to disclose
C. Tibaldi
No relevant relationships to disclose
E. F. Smit
No relevant relationships to disclose